INTELLIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.22 USD | +0.19% |
|
+7.20% | -14.00% |
| May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
| May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 26.22 | 32.80 | 32.66 |
| Spread/Res. | +0.00% | -20.06% | -19.72% |
| Spread/Supp. | +14.00% | +30.97% | +26.30% |
| Support | 23.00 | 20.02 | 20.76 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
